Predicting ten-year survival of patients with primary cutaneous melanoma: Corroboration of a prognostic model

Cancer

Volumn 80, Issue 8, 1997, Pages 1426-1431

  Sahin, Sedef ^a   Rao, Babar ^b   Kopf, Alfred W ^a,d   Lee, Eric ^a   Rigel, Darrell S ^a   Nossa, Robert ^a   Rahman, Irfan J ^a   Wortzel, Hal ^a   Marghoob, Ashfaq A ^c   Bart, Robert S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Multivariate analysis; Primary cutaneous melanoma; Prognosis; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RISK FACTOR; SKIN CANCER; STATISTICAL ANALYSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0030827897     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971015)80:8<1426::AID-CNCR9>3.0.CO;2-C     Document Type: Article

References (39)

1. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-8.
2. Mackie RM, Carfrae DC, Cochran AJ. Assessment of prognosis in patients with malignant melanoma. Lancet 1972;2: 455-6.
3. Magnus K. Prognosis in malignant melanoma of the skin: significance of stage of disease, anatomical site, sex, age, and period of diagnosis. Cancer 1977;40:389-97.
4. Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg 1978;188:732-42.
5. Schmoekel C, Braun-Falco O. Prognostic index in malignant melanoma. Arch Dermatol 1978;114:871-3.
6. Balch CM, Soong SJ, Murad TM, Ingalls RN, Maddox WA. A multifactorial analysis of melanoma: prognostic factors in patients with stage I (localized) melanoma. Surgery 1979;86: 343-51.
7. McGovern VJ, Shaw HM, Milton GW, Farago GA. Prognostic significance of the histological features of malignant melanoma. Histopathology 1979;3:385-93.
8. Cascinelli N, Morabito A, Bufalino R, Van Der Esch EP, Preda F, Vaglini M, et al. WHO Collaborating centres for evaluation of methods of diagnosis and treatment of melanoma. Int J Cancer 1980;26:733-9.
9. Day CL Jr., Lew RA, Mihm MC, Sober AJ, Harris MN, Kopf AW, et al. A multivariate analysis of prognostic factors for melanoma patients with lesions > 3.65 mm in thickness. Ann Surg 1982;195:44-9.
10. Day CL Jr., Mihm MC, Lew RA, Harris MN, Kopf AW, Fitzpatrick TB, et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm). Ann Surg 1982;195:35-43.
11. Day CL Jr., Mihm MC, Sober AJ, Harris MN, Kopf AW, Fitzpatrick TB, et al. Prognostic factors for melanoma patients with lesions 0.76-1.69 mm in thickness. Ann Surg 1982;195:30-40.
12. Friedman RJ, Rigel DS, Kopf AW, Lieblich L, Lew R, Harris MN, et al. Favorable prognosis for malignant melanoma associated with acquired melanocytic nevi. Arch Dermatol 1983;119:455-62.
13. Koh HK, Sober AJ, Kopf AW, Day CL Jr., McKusick KA, Lew RA, et al. Prognosis in stage I malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death. J Nucl Med 1984;25:1183-9.
14. Rigel DS, Rogers GS, Friedman RJ. Prognosis of malignant melanoma. Dermatol Clin 1985;3:309-14.
15. Kopf AW, Gross DF, Rogers GS, Rigel DS, Hellmann LJ, Levenstein M, et al. Prognostic index for malignant melanoma. Cancer 1987;59:1236-41.
16. Meyskens FL Jr., Berdeaux DH, Parks B, Tong T, Loescher L, Moon TE, et al. Cutaneous malignant melanoma (Arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage I disease. Cancer 1988;62:1207-14.
17. Karjalainen S, Hakulinen T. Survival and prognostic factors of patients with skin melanoma: a regression-model analysis based on nationwide cancer registry data. Cancer 1988;62: 2274-80.
18. Karakousis CP, Emrich LJ, Rao U. Tumor thickness and prognosis in clinical stage I malignant melanoma. Cancer 1989; 64:1432-6.
19. Clark WH Jr., Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989;81:1893-904.
20. Coit D, Sauven P, Brennan M. Prognosis of thick cutaneous melanoma of the trunk and extremity. Arch Surg 1990;125: 322-6.
21. Friedman RJ, Rigel DS, Kopf AW, Grin CM, Heilman E, Bart RS, et al. Volume of malignant melanoma is superior to thickness as a prognostic indicator. Dermatol Clin 1991;9: 643-8.
22. Schuchter L, Schultz DJ, Synnestvedt M, Trock BJ, Guerry DIV, Elder DE, et al. A prognostic model for predicting 10-year survival in patients with primary melanoma. Ann Intern Med 1996;125:369-75.
23. Braitman LE, Davidoff F. Predicting clinical states in individual patients [editorial]. Ann Intern Med 1996;125:406-12.
24. Clark WH Jr., From L, Bernadino EA, Mihm MC. The histogenesis and biologic behavior of primary malignant melanomas of the skin. Cancer Res 1969;29:705-26.
25. Hoshmer DW, Lemeshow S. Assessing the fit of the model. In: Applied logistic regression. New York: John Wiley & Sons, Inc., 1989:135-75.
26. SAS/STAT User's Guide. Version 6. Volume 2. 4th edition. Cary, NC: SAS Institute, 1994.
27. Rogers GS, Kopf AW, Rigel DS, Friedman RJ, Levine JL, Levenstein M, et al. Effect of anatomical location on prognosis in patients with clinical stage I melanoma. Arch Dermatol 1983;119:644-9.
28. Crowley NJ, Siegler HF. Late recurrence of malignant melanoma: analysis of 168 patients. Ann Surg 1990;212: 173-7.
29. Drzewiecki KT, Frydman H, Andersen KP, Poulsen H, Ladefoged C, Vibe P. Malignant melanoma: changing trends in factors influencing metastasis-free survival from 1964-1982. Cancer 1990;65:362-6.
30. Day CL, Sober AJ, Kopf AW, Lew RA, Mihm MC, Hennessey P, et al. A prognostic model for clinical stage 1 melanoma of the upper extremity: the importance of anatomical subsites in predicting recurrent disease. Ann Surg 1981; 193:436-40.
31. Garbe C, Buttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, et al. Primary cutaneous melanoma: prognostic classification of anatomic location. Cancer 1995;75:2492-8.
32. Cohen HJ, Cox E, Manton K, Woodbury M. Malignant melanoma in the elderly. J Clin Oncol 1987;5:100-6.
33. Austin PF, Cruse W, Lyman G, Schroer K, Glass F, Reintgen DS. Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol 1994;1:487-94.
34. Levine J, Kopf AW, Rigel DS, Bart RS, Hennessey P, Friedman RJ, et al. Correlation of thicknesses of superficial spreading melanomas and ages of the patients. J Dermatol Surg Oncol 1981;7:311-6.
35. Rivers JK, Kelly MC, Kopf AW, Welkovich BA, Bart RS. Age and malignant melanoma: comparison of variables in different age-groups. J Am Acad Dermatol 1989;21:717-22.
36. O'Doherty CJ, Prescott RJ, White H, McIntyre M, Hunter JAA. Sex differences in presentation of cutaneous malignant melanoma and in survival from stage I disease. Cancer 1986;58:788-92.
37. Vossaert KA, Silvermann MK, Kopf AW, Bart RS, Rigel DS, Friedman RJ, et al. Influence of gender on survival in patients with stage I primary melanoma. J Am Acad Dermatol 1992;26:429-40.
38. Balch CM. Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 1992;8:400-14.
39. Holland JC. Stage-specific psychological issues. In: Holland JC, Rowland JH, editors. Handbook of psychoonocology. New York: Oxford University Press, Inc., 1989:80-2.